0001845313-21-000001.txt : 20210217 0001845313-21-000001.hdr.sgml : 20210217 20210216184048 ACCESSION NUMBER: 0001845313-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210217 DATE AS OF CHANGE: 20210216 EFFECTIVENESS DATE: 20210217 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sarkana Pharma, Inc. CENTRAL INDEX KEY: 0001845313 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-389612 FILM NUMBER: 21641737 BUSINESS ADDRESS: STREET 1: 1000 N. WEST ST., SUITE 1200 CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 6493324417 MAIL ADDRESS: STREET 1: 1000 N. WEST ST., SUITE 1200 CITY: WILMINGTON STATE: DE ZIP: 19801 D 1 primary_doc.xml X0708 D LIVE 0001845313 Sarkana Pharma, Inc. 1000 N. WEST ST., SUITE 1200 WILMINGTON DE DELAWARE 19801 6493324417 DELAWARE None None Corporation true 2020 Caroline Fortier 1000 N. West St., Suite 1200 Wilmington DE DELAWARE 19801 Executive Officer Mark Cipriano 1000 N. West St., Suite 1200 Wilmington DE DELAWARE 19801 Executive Officer Luc Marengere 2 Place Alexis Nihon, Suite 902 3500 Blvd de Maisonneuve West Westmount A8 QUEBEC, CANADA H3Z 3C1 Director Pharmaceuticals Decline to Disclose 06b false 2020-12-21 false true false 0 Indefinite 1579000 Indefinite This offering was made in exchange for certain licensing rights to investor's proprietary compound, which rights were estimated to be valued at $1,579,000. false 1 0 0 0 false Sarkana Pharma, Inc. Juan Felipe Velasquez Juan Felipe Velasquez Attorney-in-Fact for Caroline Fortier, CEO 2021-02-16